Board Member

Dr. Rami El Assal

Founding Partner at Boutique Venture Partners


Dr. El Assal is a scientist-clinician turned venture capitalist investing in healthcare and life sciences. He is the Managing General Partner & Co-founder of Boutique Venture Partners, a venture capital firm specializing in early-stage investments in Biotech, Medtech, Digital Health, Health Economics, and Health Edtech startups. At Boutique, Rami has led over a dozen investments and currently serves on the Board of Directors of Filtricine.  In 2022, he was recognized among the Top 25 Healthcare Investors by Growth Cap Advisory.

Prior to founding Boutique, Rami was a Research Scientist (Academic Staff) at the Canary Center for Cancer Early Detection at Stanford University School of Medicine and is currently affiliated with the Precision Health and Integrated Diagnostic Center at Stanford University. Previously, he completed two Postdoctoral Research Fellowships at Stanford and Harvard Medical Schools. He has been recognized by several entities, such as the Center of Nanoscale Systems (CNS) at Harvard University, and published in the field of Early Detection & Early Treatment, including a two-volume book published in Springer Nature.

Our Team

Dr. John Chant
Dr. Xiyan Li
CSO & Co-founder
Dr. Jimmy Xin Wang
CTO & Co-founder
Dr. Grace Xiaolu Yang
COO, VP of Research & Co-founder
Mike Partsuf
Senior Food Scientist
Emily Sinovic
Public Relations Consultant
Todd Lorenz
Clinical Development Consultant

Our Advisors

Dr. Mike P Snyder
Chair of Genetics
Stanford University School of Medicine
Peter B Hutt
Former FDA Chief Counsel
Senior Counsel at Covington & Burling LLP
Brad Barnes
Culinary Institute of America
Dr. Dariush Mozaffarian
Dean at the School of Nutrition Science
Tufts University
Dr. Yung-Chi Cheng
Henry Bronson Professor of Pharmacology
Yale University School of Medicine
Dr. Danhua Xiao
Nutrition & Metabolic Physician Specialist
Atlantic Health Metabolic Center
Dr. Joseph V Rodricks
Founding Principal
Ramboll (formerly ENVIRON)
Alister Thomson
Bristol Myers Squibb (Former)
Jeff Depew
Board Director & Committee Chair
Sand Hill Angels
Dr. Wei Jiang
Senior Director
Medical Affairs at MorphoSys

Our Board of Directors

Dr. John Chant
Dr. Xiyan Li
CSO & Co-founder
Drew Lanza
Founding Partner at Berkeley Catalyst Fund
We are a clinical-stage biotechnology company based in the San Francisco Bay Area dedicated to developing novel food products for disease control.
© 2022 Filtricine, Inc. All Rights Reserved | by Wuilt